Hypertension and cognition

International Psychogeriatrics

Volumn 15, Issue SUPPL. 1, 2003, Pages 139-146

  Skoog, Ingmar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Blood pressure; Cognition; Dementia; Hypertension

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; NITRENDIPINE;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERTENSION; MOUSE; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 0141708605     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610203009104     Document Type: Conference Paper

References (59)

1. Adams, J., Brierley, J., Connor, R., et al. (1966). The effects of systemic hypotension upon the human brain: Clinical and neuropathological observations in 11 cases. Brain, 89, 235-267.
2. Arendash, G., Su, G., Crawford, F., et al. (1999). Intravascular beta-amyloid infusion increases blood pressure: Implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. Neuroscience Letters, 268, 17-20.
3. Arregui, A., Perry, E., Rossor, M., et al. (1982). Angiotensin converting enzyme in Alzheimer's disease: Increased activity in caudate nucleus and cortical areas. Journal of Neurochemistry, 82, 1490-1492.
4. Bader, M., Paul, M., Fernandez-Alfonso, M., et al. (1994). Molecular biology and biochemistry of the renin-angiotensin system. In J. Swales (Ed.), Textbook of hypertension. Oxford: Blackwell Scientific Publications.
5. Barnes, J., Barnes, N., Costall, B., et al. (1989). Angiotensin II inhibits the release of [3H] acetylcholine from rat entorhinal cortex in vitro. Brain Research, 492, 136-143.
6. Barnes, N., Champaneria, S., Costall, B., et al. (1990). Cognitive enhancing actions of DUP 753 detected in a mouse habituation paradigm. Neuroreport, 1, 239-242.
7. Barnes, N., Cheng, C., Costall, B., et al. (1991a). Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. European Journal of Pharmacology, 20, 289-292.
8. Barnes, N., Costall, B., Kelly, M., et al. (1991b). Cognitive enhancing actions of PD 123177 detected in a mouse habituation paradigm. Neuroreport, 2, 351-353.
9. Bennett, S. A., Pappas, B. A., Stevens, W. D., et al. (2000). Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiology of Aging, 21, 207-214.
10. Blennow, K., Wallin, A., Uhlemann, C., et al. (1991). White-matter lesions on CT in Alzheimer patients: Relation to clinical symptomatology and vascular factors. Acta Neurologica Scandinavica, 83, 187-193.
11. Brun, A., & Englund, E. (1986). A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Annals of Neurology, 19, 253-262.
12. Burke, W., Coronado, P., Schmitt, C., et al. (1994). Blood pressure regulation in Alzheimer's disease. Journal of the Autonomic Nervous System, 48, 65-71.
13. de la Torre, J. (2000). Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Disease and Associated Disorders, 14(Suppl. 1), S72-S81.
14. De Reuck, J., Crevits, L., De Coster, W., et al. (1980). Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology, 30, 920-928.
15. Ekeberg, O., Kjeldsen, S., Eide, I., et al. (1990). Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension. Journal of Psychosomatic Research, 34, 643-649.
16. Forette, F., Seux, M.-L., Staessen, J., et al. (1998). Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (syst-Eur) trial. Lancet, 352, 1347-1351.
17. Guo, Z., Fratiglioni, L., Viitanen, M., et al. (2001). Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: Variation by use of antihypertensive medication? American Journal of Epidemiology, 153, 225-231.
18. Guo, Z., Fratiglioni, L., Zhu, L., et al. (1999a). Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Archives of Neurology, 56, 991-996.
19. Guo, Z., Viitanen, M., Fratiglioni, L., et al. (1996). Low blood pressure and dementia in elderly people: The Kungsholmen project. British Medical Journal, 312, 805-808.
20. Guo, Z., Viitanen, M., Winblad, B., et al. (1999b). Low blood pressure and incidence of dementia in a very old sample: Dependent on initial cognition. Journal of the American Geriatrics Society, 47, 723-726.
21. Hall, E., Oostveen, J., Dunn, E., et al. (1995). Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Experimental Neurology, 135, 17-27.
22. Hardy, J., Mann, D., Wester, P., et al. (1986). An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiology of Aging, 7, 489-502.
23. Heyman, A., Fillenbaum, G., Welsh-Bohmer, K., et al. (1998). Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology, 51, 159-162.
24. Hogan, D., Ebly, E., & Rockwood, K. (1997). Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders, 8, 147-151.
25. Holmes, C., Cairns, N., Lantos, P., et al. (1999). Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry, 174, 45-50.
26. in't Veld, B. A., Ruitenberg, A., Hofman, A., et al. (2001). Antihypertensive drugs and incidence of dementia: The Rotterdam Study. Neurobiology of Aging, 22, 407-412.
27. Jendroska, K., Poewe, W., Daniel, S., et al. (1995). Ischemic stress induces deposition of amyloid b immunoreactivity in human brain. Acta Neuropathologica, 90, 461-466.
28. Johansson, B. (1994). Pathogenesis of vascular dementia: The possible role of hypertension. Dementia, 5, 174-176.
29. Kalaria, R., Bhatti, S., Palatinsky, E., et al. (1993). Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport, 4, 211-214.
30. Kivipelto, M., Helkala, E.-L., Laakso, M., et al. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. British Medical Journal, 322, 1447-1451.
31. Launer, L. J., Ross, G. W., Petrovitch, H., et al. (2000). Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiology of Aging, 21, 49-55.
32. Lim, A., Tsuang, D., Kukull, W., et al. (1999). Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. Journal of the American Geriatrics Society, 47, 564-569.
33. Lotz, P., Ballinger, W., Jr., & Quisling, R. (1986). Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation. AJNR: American Journal of Neuroradiology, 7, 817-822.
34. Mann, D., Davies, J., Hawkes, J., et al. (1982). Immunohistochemical staining of senile plaques. Neuropathology and Applied Neurobiology, 8, 55-61.
35. Nag, S. (1984). Cerebral changes in chronic hypertension: Combined permeability and immunohistochemical studies. Acta Neuropathologica (Berlin), 62, 178-184.
36. Nagy, Z., Esiri, M., Jobst, K., et al. (1997). The effects of additional pathology on the cognitive deficit in Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 56, 165-170.
37. Passant, U. (1996). Posture and brain function in dementia. A study with special reference to orthostatic hypotension [Thesis]. Lund: University of Lund.
38. Persson, G., & Skoog, I. (1996). A prospective population study of psychosocial risk factors for late-onset dementia. International Journal of Geriatric Psychiatry, 11, 15-22.
39. Petrovitch, H., White, L. R., Izmirilian, G., et al. (2000). Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Honolulu-Asia aging Study. Neurobiology of Aging, 21, 57-62.
40. Richards, S. S., Emsley, C. L., Roberts, J., et al. (2000). The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. Journal of the American Geriatrics Society, 48, 1035-1041.
41. Roman G. (1987). Senile dementia of the Binswanger type: A vascular form of dementia in the elderly. Journal of the American Medical Association, 258, 1782-1788.
42. Ruitenberg, A. (2000). Vascular factors in Dementia: Observations in the Rotterdam Study. Rotterdam: Erasmus University.
43. Ruitenberg A., Skoog, I., Ott, A., et al. (2001). Blood pressure and risk of dementia: Results from the Rotterdam Stund the Gothenburg H-70 Study. Dementia and Geriatric Cognitive Disorders 33-39.
44. Shah, G. & Mooradian, A. D. (1997). Age-related changes in the blood-brain barrier. Experimental Gerontology, 32, 501-519
45. Skoog, I. (1997). The relationship between blood pressure and dementia: A review. Biomedicine and Pharmacotherapy, 51, 367-375.
46. Skoog, I. (1998). A review on blood pressure and ischamic white matter lesions. Dementia and Geriatric Cognitive Disorders, 9(Suppl. 1), 13-19.
47. Skoog, I. (1999a). The interaction between vascular disorders and Alzheimer's disease. In K. Iqbal, D. Swaab, B. Winblad, et al., Eds., Alzheimer's disease and related disorders; Etiology, pathogenesis and therapeutics (pp. 523-530). Chichester: John Wiley & Sons.
48. Skoog, I. (1999b). Possibilities for secondary prevention of Alzheimer's disease. In R. Mayeux & Y. Christen (Eds.), The epidemiology of Alzheimer'a disease. From gene to prevention. Berlin: Springer-Verlag.
49. Skoog, I., Andreasson, L. A., Landahl, S., et al. (1998a). A population-based study on blood pressure and brain atrophy in 85-year-olds. Hypertension, 32, 404-409.
50. Skoog, I., Lernfelt, B., & Landahl, S. (1996a). High blood pressure and dementia. Lancet, 348, 65-66.
51. Skoog, I., Lernfelt, B., Landahl, S., et al. (1996b). 15-year longitudinal study of blood pressure and dementia [see comments]. Lancet, 347, 1141-1145.
52. Skoog, I., Palmertz, B., & Andreasson, L. A. (1994). The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds. Journal of Geriatric Psychiatry and Neurology, 7, 169-175.
53. Skoog, I., Wallin, A., Fredman, P., et al. (1998b). A population study on blood-brain barrier function in 85-year-olds: Relation to Alzheimer's disease and vascular dementia. Neurology, 50, 966-971.
54. Snowdon, D., Greiner, L., Mortimer, J., et al. (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Journal of the American Medical Association, 277, 813-817.
55. Sparks, D. L., Scheff, S. W., Liu, H., et al. (1995). Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. Journal of the Neurological Sciences, 131, 162-169.
56. Stephenson, D. T., Rash, K., & Clemens, J. A. (1992). Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Research, 593, 128-135.
57. Struijker Boudier, H. (1994). Vascular growth and hypertension. In J. Swales (Ed.), Textbook of hypertension. Oxford: Blackwell Scientific Publications.
58. Wisniewski, H., & Kozlowski, P. (1982). Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Annals of the New York Academy of Sciences, 396, 119-131.
59. Wright, J., & Harding, J. (1994). Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neuroscience and Biobehavioral Reviews, 18, 21-53.